Granules India Ltd

Granules India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Granules India Ltd

₹ 469 -1.01%
11 Jul - close price
granulesindia.com BSE: 532482 NSE: GRANULES
About

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]

Key Points

Business Segments

Website BSE NSE
  • Market Cap ₹ 11,380 Cr.
  • Current Price ₹ 469
  • High / Low ₹ 725 / 412
  • Stock P/E 23.7
  • Book Value ₹ 153
  • Dividend Yield 0.32 %
  • ROCE 15.1 %
  • ROE 13.8 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • The company has delivered a poor sales growth of 11.5% over past five years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 7.75% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -3.16%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Pharma

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1,030 1,020 1,151 1,146 1,196 986 1,189 1,156 1,176 1,180 967 1,138 1,197
837 808 908 915 967 849 977 905 920 921 763 907 945
Operating Profit 193 212 243 231 228 137 213 250 256 259 203 230 252
OPM % 19% 21% 21% 20% 19% 14% 18% 22% 22% 22% 21% 20% 21%
4 5 5 1 3 0 2 1 2 2 3 6 33
Interest 6 7 13 17 19 22 26 29 29 27 26 27 24
Depreciation 40 43 44 48 49 49 53 52 53 53 53 57 64
Profit before tax 150 166 190 167 164 65 136 170 176 181 128 153 198
Tax % 26% 23% 24% 26% 27% 27% 25% 26% 26% 26% 24% 23% 23%
111 128 145 124 120 48 102 126 130 135 97 118 152
EPS in Rs 4.48 5.14 5.84 5.14 4.94 1.98 4.21 5.18 5.35 5.56 4.01 4.85 6.27
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,084 1,292 1,357 1,411 1,685 2,279 2,599 3,238 3,765 4,512 4,506 4,482
925 1,082 1,081 1,112 1,406 1,895 2,073 2,382 3,038 3,597 3,648 3,536
Operating Profit 159 210 276 299 278 384 526 856 727 915 858 945
OPM % 15% 16% 20% 21% 17% 17% 20% 26% 19% 20% 19% 21%
4 3 5 35 27 75 90 26 13 12 2 44
Interest 20 32 37 32 33 28 27 26 23 56 106 103
Depreciation 30 53 58 72 76 105 137 151 159 184 207 226
Profit before tax 112 128 186 230 196 326 451 704 558 687 547 660
Tax % 33% 29% 33% 28% 32% 27% 26% 22% 26% 25% 26% 24%
75 91 123 165 133 236 335 549 413 517 405 502
EPS in Rs 3.71 4.45 5.68 7.19 5.22 9.30 13.19 22.18 16.64 21.34 16.72 20.68
Dividend Payout % 9% 11% 11% 13% 19% 11% 8% 7% 9% 7% 9% 7%
Compounded Sales Growth
10 Years: 13%
5 Years: 12%
3 Years: 6%
TTM: -1%
Compounded Profit Growth
10 Years: 18%
5 Years: 9%
3 Years: 5%
TTM: 18%
Stock Price CAGR
10 Years: 17%
5 Years: 14%
3 Years: 16%
1 Year: -9%
Return on Equity
10 Years: 17%
5 Years: 17%
3 Years: 15%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 20 20 22 23 25 25 25 25 25 24 24 24
Reserves 336 411 640 881 1,279 1,504 1,818 2,149 2,562 2,811 3,201 3,691
442 482 641 656 978 991 892 849 1,106 1,136 1,315 1,455
194 289 260 319 388 458 487 690 819 932 957 1,082
Total Liabilities 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,903 5,498 6,253
482 617 560 644 777 944 1,204 1,332 1,541 1,911 2,096 2,430
CWIP 125 62 77 267 515 496 294 239 356 239 272 437
Investments 0 0 70 108 157 210 19 19 20 21 22 22
385 524 856 859 1,222 1,328 1,706 2,123 2,594 2,732 3,109 3,364
Total Assets 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,903 5,498 6,253

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
108 150 151 188 -1 262 476 432 332 739 439 867
-255 -146 -162 -326 -462 -270 -160 -277 -379 -192 -358 -691
147 19 86 56 529 -17 -213 -299 190 -440 8 -93
Net Cash Flow 0 24 75 -82 66 -25 103 -144 143 107 90 83

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 37 39 101 108 136 108 93 86 90 77 80 77
Inventory Days 99 110 128 145 114 112 125 205 190 182 235 284
Days Payable 77 92 91 116 112 94 102 142 124 124 135 154
Cash Conversion Cycle 59 57 138 137 138 126 116 150 156 135 179 207
Working Capital Days 48 41 115 120 156 120 116 109 119 102 121 122
ROCE % 20% 19% 20% 18% 12% 15% 17% 25% 17% 19% 15% 15%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
41.93% 42.02% 42.02% 42.02% 41.97% 41.97% 41.96% 38.87% 38.87% 38.85% 38.83% 38.82%
22.35% 23.66% 23.90% 21.35% 21.48% 18.78% 19.57% 20.39% 19.49% 15.87% 15.14% 13.24%
4.32% 4.75% 5.03% 6.68% 7.06% 10.16% 10.70% 14.11% 14.85% 19.57% 22.45% 23.52%
31.40% 29.56% 29.05% 29.95% 29.51% 29.10% 27.77% 26.61% 26.80% 25.71% 23.56% 24.41%
No. of Shareholders 2,16,0551,90,8941,87,7772,01,0542,07,0551,90,6911,82,1421,79,8702,02,1981,77,5541,69,8021,69,700

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls